Patent · US Active

BTNL3/8 targeting constructs for delivery of payloads

US12152064B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

King's College London and GammaDelta Therapeutics Limited · GB

Inventors

Oliver NUSSBAUMER · London, GB
Oxana Polyakova · London, GB
Raj J. Mehta · Ambawadi, IN
Adrian Hayday · Ashford, GB
Pierre VANTOUROUT · London, GB
Iva ZLATAREVA · London, GB
Daisy MELANDRI · London, GB
Robin John Campbell DART · London, GB
Adam LAING · London, GB

Key dates

Filing date	Jun 5, 2019
Grant date	Nov 26, 2024
Priority date	—
Expiry date	Oct 21, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/565
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Protein constructs comprising a BTNL3/8 targeting moiety, a payload and an optional linker are described herein. Pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.